Cancer medicines
Acalabrutinib
Acalabrutinib
A BTK-targeted medicine for CLL/SLL and selected mantle cell lymphomas.
Sources checked · Introductory guide
On this page
How it works
It blocks BTK signaling to inhibit malignant B-cell growth.[3]
Where it is used
Used in selected CLL/SLL or mantle cell lymphoma with regimen and prior treatment reviewed.[1]
Key safety points
Report fever, severe bleeding, palpitations or faintness immediately. Discuss surgery, dental procedures and all medicines in advance.[2]
Questions for your care team
- What combination, infection or bleeding prevention and procedure plan apply to me?
Sources and scope
Source documents are in English.
Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.
- NCI · Acalabrutinib Maleate Monohydrate (opens in a new tab)
- MedlinePlus · Acalabrutinib Maleate Monohydrate (opens in a new tab)
- NCI Drug Dictionary · Acalabrutinib Maleate Monohydrate (opens in a new tab)
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.